MedPath

Fertility After Intrauterine Tamponing Balloon: Where Are we

Completed
Conditions
Hemorrhage Postpartum
Fertility Disorders
Registration Number
NCT04133402
Lead Sponsor
University Hospital, Lille
Brief Summary

Today, few data are available on the patient's fertility following intrauterine tamponade balloon (BTIU) used for postpartum hemorrhage (PPH) after vaginal delivery (AVB). Several studies have concluded that there are no fertility disorders after conservative surgical treatment or embolization. BTIU is an essential treatment in the management of PPH. The aim was to evaluate post-BTIU fertility and the appearance of gynecological symptoms.

This is a bicentric retrospective study (Valenciennes, Lille, France), between 2012 and 2017. The data will be collected by telephone interview on fertility and various gynecological functional symptoms.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
59
Inclusion Criteria
  • Vaginal birth
  • Post partum haemorrhage
  • Intrauterine tamponing balloon
  • Between 2012 and 2017
  • CHRU Lille and CH Valenciennes
Exclusion Criteria
  • Minor patients
  • Initial intake started in another center (postpartum transfer).
  • Refusal to participate in the study
  • Invasive treatments for postpartum haemorrhage
  • Caesarean

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of infertility7 years

defined as the absence of pregnancy after 12 months of attempted pregnancy.

Secondary Outcome Measures
NameTimeMethod
Type of gynecological complications after use of an intrauterine tamponade balloon.7 years

type = infections , pelvic pain, cycle disorders

type of obstetrical complications7 years

complications = intrauterine growth retardation, threat of premature labor

the frequency of obstetric complications for the next pregnancy7 years
Time to obtain a new pregnancy evaluating the stop of contraceptionand desire for pregnancy7 years
Frequency of gynecological complications after use of an intrauterine tamponade balloon.7 years
Frequency of recurrent postpartum haemorrhage in the next pregnancy7 years

Trial Locations

Locations (1)

Hôpital Roger Salengro, CHU

🇫🇷

Lille, France

© Copyright 2025. All Rights Reserved by MedPath